The GLP-1 and GIP receptors in the digestive system slow gastric emptying
With regard to the utility of GLP-1R agonists in myocardial IRI, the first report by Nikolaidis et al
7.5 A Phase II Study of Liraglutide (Victoza , Saxenda ) in PD A randomized, double-blind, placebo-controlled phase II clinical trial suggested that liraglutide has protective effects in patients with PD (NCT02953665)
ArticlePubMed 58
Zepbound activates the receptors of two hormones: glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) to help regulate blood sugar, curb appetite, and support sustainable weight loss
Kaiser-Kupfer MI, Gazzo MA, Datiles MB, Caruso RC, Kuehl EM, Gahl WA (1990) A randomized placebo-controlled trial of cysteamine eye drops in nephropathic cystinosis